S&P 500   3,037.88 (-2.52%)
DOW   26,291.61 (-2.47%)
QQQ   210.00 (-2.99%)
AAPL   280.40 (-4.19%)
FB   191.78 (-2.75%)
MSFT   165.15 (-2.95%)
GOOGL   1,353.55 (-2.66%)
AMZN   1,915.23 (-3.25%)
CGC   18.33 (-7.52%)
NVDA   253.49 (-5.29%)
BABA   203.10 (-2.70%)
MU   50.37 (-3.82%)
GE   10.47 (-4.39%)
TSLA   677.40 (-13.02%)
AMD   43.52 (-8.36%)
T   36.07 (-2.78%)
ACB   1.37 (-9.27%)
F   6.97 (-3.33%)
NFLX   388.72 (+2.50%)
BAC   29.38 (-4.08%)
DIS   119.70 (-2.97%)
GILD   75.02 (+0.43%)
S&P 500   3,037.88 (-2.52%)
DOW   26,291.61 (-2.47%)
QQQ   210.00 (-2.99%)
AAPL   280.40 (-4.19%)
FB   191.78 (-2.75%)
MSFT   165.15 (-2.95%)
GOOGL   1,353.55 (-2.66%)
AMZN   1,915.23 (-3.25%)
CGC   18.33 (-7.52%)
NVDA   253.49 (-5.29%)
BABA   203.10 (-2.70%)
MU   50.37 (-3.82%)
GE   10.47 (-4.39%)
TSLA   677.40 (-13.02%)
AMD   43.52 (-8.36%)
T   36.07 (-2.78%)
ACB   1.37 (-9.27%)
F   6.97 (-3.33%)
NFLX   388.72 (+2.50%)
BAC   29.38 (-4.08%)
DIS   119.70 (-2.97%)
GILD   75.02 (+0.43%)
S&P 500   3,037.88 (-2.52%)
DOW   26,291.61 (-2.47%)
QQQ   210.00 (-2.99%)
AAPL   280.40 (-4.19%)
FB   191.78 (-2.75%)
MSFT   165.15 (-2.95%)
GOOGL   1,353.55 (-2.66%)
AMZN   1,915.23 (-3.25%)
CGC   18.33 (-7.52%)
NVDA   253.49 (-5.29%)
BABA   203.10 (-2.70%)
MU   50.37 (-3.82%)
GE   10.47 (-4.39%)
TSLA   677.40 (-13.02%)
AMD   43.52 (-8.36%)
T   36.07 (-2.78%)
ACB   1.37 (-9.27%)
F   6.97 (-3.33%)
NFLX   388.72 (+2.50%)
BAC   29.38 (-4.08%)
DIS   119.70 (-2.97%)
GILD   75.02 (+0.43%)
S&P 500   3,037.88 (-2.52%)
DOW   26,291.61 (-2.47%)
QQQ   210.00 (-2.99%)
AAPL   280.40 (-4.19%)
FB   191.78 (-2.75%)
MSFT   165.15 (-2.95%)
GOOGL   1,353.55 (-2.66%)
AMZN   1,915.23 (-3.25%)
CGC   18.33 (-7.52%)
NVDA   253.49 (-5.29%)
BABA   203.10 (-2.70%)
MU   50.37 (-3.82%)
GE   10.47 (-4.39%)
TSLA   677.40 (-13.02%)
AMD   43.52 (-8.36%)
T   36.07 (-2.78%)
ACB   1.37 (-9.27%)
F   6.97 (-3.33%)
NFLX   388.72 (+2.50%)
BAC   29.38 (-4.08%)
DIS   119.70 (-2.97%)
GILD   75.02 (+0.43%)
Log in

Aptevo Therapeutics SEC Filings & 10K Form (NASDAQ:APVO)

$0.42
-0.02 (-4.59 %)
(As of 02/27/2020 10:18 AM ET)
Today's Range
$0.41
Now: $0.42
$0.44
50-Day Range
$0.44
MA: $0.57
$0.70
52-Week Range
$0.41
Now: $0.42
$1.72
Volume92,957 shs
Average Volume548,826 shs
Market Capitalization$18.81 million
P/E RatioN/A
Dividend YieldN/A
Beta2.51

SEC Filings

Aptevo Therapeutics (NASDAQ:APVO) SEC Filings

DateFilerForm TypeView
01/31/2020
4:21 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
11/07/2019
11:53 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
11:39 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
7:56 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:55 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:54 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:53 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:52 PM
Aptevo Therapeutics (Issuer)
Gross Jane A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
7:50 PM
Adelman Michael (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:32 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
5:35 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
3:31 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
3:48 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
7:29 AM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
8:46 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
7:02 AM
Aptevo Therapeutics (Filer)
Form 424B5
08/09/2019
11:26 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
11:19 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
5:49 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2019
5:49 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2019
3:19 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2019
5:18 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
4:12 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
3:50 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2019
4:54 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
11:41 AM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
3:10 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
6:11 PM
Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
12:58 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
1:57 PM
Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
2:19 PM
Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
2:18 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
12:02 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
12:01 PM
Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
12:00 PM
Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
11:59 AM
Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
11:58 AM
Aptevo Therapeutics (Issuer)
Niederhuber John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
11:54 AM
Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
5:12 PM
Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
6:22 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
8:27 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
9:00 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
8:01 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2019
5:03 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
4:14 PM
Aptevo Therapeutics (Filer)
Form DEFA14A
04/05/2019
4:12 PM
Aptevo Therapeutics (Filer)
Form DEF 14A
03/22/2019
3:16 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
4:20 PM
Aptevo Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
03/20/2019
2:58 PM
Aptevo Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G
03/18/2019
3:56 PM
Aptevo Therapeutics (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
03/18/2019
1:01 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
12:33 PM
Aptevo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
3:28 PM
Aptevo Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
03/11/2019
8:21 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
5:13 AM
Aptevo Therapeutics (Filer)
Form 424B5
03/06/2019
4:29 PM
Aptevo Therapeutics (Filer)
Form 424B5
03/04/2019
8:10 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:09 PM
Aptevo Therapeutics (Issuer)
Stromatt Scott C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:08 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:06 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:05 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:04 PM
Aptevo Therapeutics (Issuer)
Gross Jane A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
8:03 PM
Adelman Michael (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
4:04 PM
Aptevo Therapeutics (Filer)
Form 424B5
02/12/2019
2:47 PM
Aptevo Therapeutics (Subject)
Sessa Capital , L.P. (0001618360) (Filed by)
Form SC 13G/A
02/12/2019
1:18 PM
Aptevo Therapeutics (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/08/2019
6:52 AM
Aptevo Therapeutics (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
01/02/2019
4:15 PM
Aptevo Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/07/2018
5:28 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
9:23 AM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
3:45 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
7:38 PM
Adelman Michael (Reporting)
Aptevo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/10/2018
7:37 PM
Aptevo Therapeutics (Issuer)
Mitchell Shawnte (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2018
1:37 PM
Aptevo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2018
12:56 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
8:06 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
4:19 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2018
3:15 PM
Aptevo Therapeutics (Filer)
Form 10-K/A
06/04/2018
5:55 PM
Aptevo Therapeutics (Issuer)
Niederhuber John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:54 PM
Aptevo Therapeutics (Issuer)
Kunz Barbara Lopez (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:53 PM
Aptevo Therapeutics (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:52 PM
Aptevo Therapeutics (Issuer)
Grant Grady III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:49 PM
Aptevo Therapeutics (Issuer)
El-Hibri Fuad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:48 PM
Abdun-Nabi Daniel (Reporting)
Aptevo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2018
4:15 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2018
3:08 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2018
1:26 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
8:01 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/20/2018
12:05 PM
Aptevo Therapeutics (Filer)
Form DEFA14A
04/20/2018
12:01 PM
Aptevo Therapeutics (Filer)
Form DEF 14A
03/21/2018
2:15 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4/A
03/21/2018
10:57 AM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
8:41 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
8:40 PM
Aptevo Therapeutics (Issuer)
Stromatt Scott C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
8:39 PM
Aptevo Therapeutics (Issuer)
Maddux Randy Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
8:37 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
8:36 PM
Aptevo Therapeutics (Issuer)
Gross Jane A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
2:45 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2018
5:04 AM
Aptevo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2018
6:38 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel